Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

M&A

Group By Ticker
Sort By
Newest | Oldest
Read More
3 minute read
  • Cannabis
  • M&A
  • Markets
  • News
  • Penny Stocks
  • Small Cap

Cannabis Giant SNDL Grows Bigger: Finalizes Valens Acquisition Becoming ‘A Leader And Trusted Partner’ In Canadian Marijuana Space

By Vuk Zdinjak
January 17, 11:31 AM
SNDL Inc. (NASDAQ: SNDL) completed the previously disclosed acquisition of all of the issued and outstanding common shares of The V

SNDL

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • M&A
  • News
  • Penny Stocks

Leap Therapeutics Shares Fall After Flame Biosciences Acquisition

By Vandana Singh
January 17, 10:24 AM
Leap Therapeutics Inc (NASDAQ:LPTX) has agreed to acquire Flame Biosciences Inc, a privately-held biotechnology company, in an all-stock transaction. The deal…

LPTX

Read More
1 minute read
  • M&A
  • News

Fintech Ecosystem Development Corp. Announces Extension Of Deadline To Complete Business Combination To April 21, 2023

By Benzinga Newsdesk
January 17, 10:08 AM
Fintech Ecosystem Development Corp. (NASDAQ:FEXD) ("FEXD") announced today that its board of directors has elected to extend the date by which FEXD has to consummate a business combination from January 21, 2023

FEXD

Read More
1 minute read
  • Earnings
  • General
  • M&A
  • Markets
  • News

Whirlpool To Offload Majority Of Its EMEA Operations, Forms New Europe Focus Entity

By Vandana Singh
January 17, 7:59 AM
Whirlpool Corporation (NYSE:WHR) has completed a strategic review of its Europe, Middle East, and Africa (EMEA) business and entered…

WHR

Read More
1 minute read
  • M&A

Calyxt And Cibus Announce All-Stock Merger Agreement; Calyxt To Issue Shares In Exchange Ratio Such That Calyxt Shareholders Will Own ~5% Of Combined Co.

By Benzinga Newsdesk
January 17, 7:32 AM
Under the terms of the merger agreement, Calyxt will issue shares of its common stock to Cibus shareholders in an exchange ratio such that upon completion of the merger, Calyxt shareholders will own

CLXT

Read More
1 minute read
  • Legal
  • M&A
  • Management
  • News

Elon Musk, Tesla Set To Go To Trial Tuesday Over 2018 Tweet That Funding Was Secured to Take the Company Private

By Charles Gross
January 17, 7:08 AM
https://www.reuters.com/article/tesla-musk-trial/tesla-musk-face-trial-in-shareholder-case-over-2018-tweets-idUSL1N33X2CS

TSLA

Read More
1 minute read
  • M&A
  • News
  • Rumors

Bloomberg Reported Emerson Set To Bid ~$53/Share for National Instruments

By Charles Gross
January 17, 6:16 AM
https://www.bloomberg.com/news/articles/2023-01-17/emerson-said-set-to-reveal-7-billion-national-instruments-bid?utm_source=google&utm_medium=bd&cmpId=google&sref=y3YMCJ4e&leadSource=uverify%20wall

EMR

Read More
1 minute read
  • M&A
  • News
  • Penny Stocks

Elicio Therapeutics and Angion Enter into Definitive Merger Agreement

By Charles Gross
January 17, 6:03 AM
Elicio Therapeutics, a privately-held, clinical-stage biotechnology company developing a pipeline of novel immunotherapies for the treatment of cancer and other diseases, has entered into a definitive merger agreement with Angion Biomedica Corp (NASDAQ: ANGN) under which Elicio will merge with a wholly-owned subsidiary of Angi

ANGN

Read More
2 minute read
  • Asia
  • Buybacks
  • M&A
  • Markets
  • Media
  • News
  • Top Stories

Ryan Cohen Takes Stake In Alibaba — Nudges Board To Boost Share Buybacks By Another $20B: WSJ

By Bhavik Nair
January 16, 9:18 PM
Activist investor Ryan Cohen has reportedly acquired a stake in Chinese e-commerce giant Alibaba Group Holding Ltd. (NYSE: 

AAPL

Read More
2 minute read
  • Eurozone
  • Gaming
  • General
  • M&A
  • Markets
  • Media
  • Tech
  • Top Stories

Microsoft’s Pending Activision Blizzard Deal Faces New EU Antitrust Challenge: Report

By Melanie Schaffer
January 16, 12:30 PM
Microsoft Corporation (NASDAQ: MSFT) was hit with another setback Monday over its bid to acquire Activision Blizzard, Inc (NASDAQ: ATVI), this time from the European Commission, which has concerns surrounding the deal.<

ATVI

Posts pagination

Previous 1 … 327 328 329 … 448 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service